Showing results (1571-1580 of 3,862) with videos related to
Sort By:
Pageof 387
Cancer Cell|January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsTracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.Cancer Cell|July 7, 2007
RXR is an essential component of the oncogenic PML/RARA complex in vivoJun Zhu, Rihab Nasr, Laurent Pérès, et al.Cancer Cell|May 16, 2006
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in gliomaQi-Wen Fan, Zachary A Knight, David D Goldenberg, et al.Cancer Cell|May 16, 2006
The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humansDaniel R Carrasco, Tim Fenton, Kumar Sukhdeo, et al.Cancer Cell|June 13, 2006
Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancersIan J Davis, Jessica J Kim, Fatih Ozsolak, et al.Cancer Cell|October 19, 2006
Regulation of androgen receptor activity by tyrosine phosphorylationZhiyong Guo, Bojie Dai, Tianyun Jiang, et al.Cancer Cell|July 9, 2010
Testimony from the bedside: from Coley's toxins to targeted immunotherapyJin Mo Park, David E FisherCancer Cell|August 17, 2010
SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancerAhmed Ashour Ahmed, Zhen Lu, Nicholas B Jennings, et al.Cancer Cell|August 17, 2010
The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunitySaeGwang Park, Zhujun Jiang, Eric D Mortenson, et al.Pageof 387